Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data

Fig. 3

Initiation of Rhythm Control Medications, Electrical Cardioversion within 30 Days of Atrial Fibrillation Diagnosis. The upper panel shows trends in the initiation of rhythm control therapy within 30 days and 180 days of atrial fibrillation diagnosis. The lower panel shows trends in electrical cardioversion procedures within 30 days of atrial fibrillation diagnosis. All outcomes are expressed in 30-day intervals, from 01/01/2016 to 09/30/2021

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us